90% of US Adults Affected by Condition Most People Have Never Heard Of

A recent survey from the American Heart Association asked 4,007 adults a series of questions about CKM health and found that ...

Targeted immunotherapy combination offers hope to older adults with leukemia

Researchers from the Alliance for Clinical Trials in Oncology have found that two targeted immunotherapy drugs lead to high ...
24/7 Wall St. on MSN

Rates Going Lower Next Week: Our Top 5% Dividend Picks Could Soar

These dividend stocks are waiting for growth and income investors to step up to the plate. Plus, they are rated Buy at top ...
The Nation UAE on MSN

Meeting mulls improving thalassemia prevention, bone marrow transplants

A meeting was held on Tuesday under the chair­manship of Federal Health Minister Mustafa Kamal to dis­cuss strategies for preventing thalassemia and making bone marrow transplants more accessible to ...

Study unveils mechanisms driving axonal accumulation of TDP-43 and associated nerve damage in ALS

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscle wasting and limb ...
Daily Mirror

India’s rising developmental & humanitarian leadership in South Asia

India has emerged as South Asia’s humanitarian and developmental leader, extending over USD 30 billion during the last 10 years in aid through financial, in-kind, and capacity-building support. Guided ...

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals Incorporated: Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK at the North American Cystic Fibrosis Conference

Data presented on outcomes following treatment with CFTR modulators add to growing body of evidence that reduced level of sweat chloride is associated with improved clinical outcomes, particularly ...

New blood test could streamline Alzheimer's diagnosis and treatment access

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve Alzheimer's disease diagnosis, potentially making it easier for patients to ...